GCP ClinPlus: China CRO Clinical Trial Research Service & Solution Company

- English





China's Premier CRO: 22 Years of Excellence Where Speed Meets Quality in Clinical Trials

Accelerating Clinical Trials with Precision — GCP ClinPlus offers rapid patient enrollment, top-tier data quality, and regulatory compliance. Trusted by global biopharma for over 22 years. Always ensuring accountability for timelines and costs.

Let's Talk

China's Premier CRO: 22 Years of Excellence Where Speed Meets Quality in Clinical Trials

Yonghong HaoExecutive President

18 years of experience in clinical research, Led biometrics strategy and statistical analysis for 200+ trials and 100+ FDA submissions

GCP ClinPlus Biometrics Resources

After nearly 20 years in biostatistics, I've learned that behind every successful submission is a team that values data quality & scientific integrity. At GCP ClinPlus, we take pride in doing the work carefully—because we know patients are waiting.

Emily YingExecutive Vice President

17+ years of experience in clinical research industry, Led 90+ major projects, Former executive at Global CRO & Biotechs, Project experience covers Phase l-V, CGT Instructor of Yihong Business School

GCP ClinPlus CGT Capabilities

With over a decade in CGT clinical development, I've seen how the right support can make all the difference. At GCP ClinPlus, we're not just a CRO—we're a committed partner helping CGT innovators navigate challenges to deliver hope to patients faster.

Betty SongVice President of Quality Assurance

20+ years of clinical research experience, Former executive roles at lQVlA, Ribo, Quintiles & Medtronic

GCP ClinPlus QA Services

Quality is the foundation of successful clinical development. Having led and supported over 100 studies, I know that trust is earned through consistency, transparency, and a relentless focus on detail.

Why China?

Fast patient enrollment, 50–70% lower costs, global regulatory alignment, 1,400+ GCP-compliant sites, and supportive NMPA policies make China ideal for clinical trials.

Why GCP ClinPlus?

22 years of experience, 2,200+ trials, 200+ NDA approvals, one-stop services, global biometrics, and expertise in advanced therapies—streamlining your trials from IND to commercialization.

Let's Talk



2200+

Projects

30+

Offices in China and the US

210+

Approvals from NMPA, FDA & EMA

Years of Clinical Trial Expertise

500+

Global Clients

400+

Global Employees

GCP ClinPlus Clients

End-to-End Clinical Research Solutions
From Protocol to Approval

At GCP ClinPlus, we deliver end-to-end clinical research solutions—from early-phase development, pivotal studies to post-marketing support—designed to accelerate timelines, improve efficiency, and reduce costs. Our integrated services include statistical support, regulatory consulting, and comprehensive clinical operations for innovative drugs, advanced therapies, medical devices, and a broad range of therapeutic areas. With seamless collaboration across operational and functional teams, we ensure your projects move forward efficiently and successfully.

Providing end-to-end clinical trial management with precision, speed, and regulatory excellence. Explore More

Accurate data and efficient decision-making, supported by an independent technology platform & a professional team, offer comprehensive biostatistical & data management services for clinical trials. Explore More

Our expert team delivers high-quality clinical & regulatory documents, from protocols to NDAs, meeting global standards. With experience in 200+ filings, we help you communicate science clearly and meet timelines confidently. Explore More

Our core team, each with over 10 years of experience, provides vigilant medical oversight to ensure patient safety, data integrity, and protocol compliance across all trial phases. Explore More

We guide clients in shaping effective clinical development strategies and provide regulatory insights to execute them seamlessly—from IND to NDA and beyond. Explore More

We ensure drug safety through end-to-end PV services, including case processing, signal detection, and regulatory reporting—delivered by an experienced team aligned with global compliance standards. Explore More

Professional quality assurance team with a robust quality management system. Explore More

Our centralized monitoring team uses real-time data analytics to detect risks early, ensure data quality, and improve trial efficiency—supporting faster, smarter decision-making. Explore More

Strategic & Registration Affairs

Pharmacovigilance

Quality Assurance

Centralized Monitoring

Therapeutic Expertise Across Innovative Medicine & Specialty Indications

PursueCRO: A Strategic Partner in Clinical Research for Global Pharmaceutical Companies

Cell & Gene Therapy (CGT)

Led the domestic first stem cell therapy.

Endocrinology & Metabolism

Integrated national research resources, optimized clinical trial processes and data quality.

Oncology

Collaborated with regions like China, the US, Europe, Japan, and South Korea to conduct trials and accelerate the market launch of innovative therapies.

Rare Disease

Assist in addressing stringent regulatory requirements and promote the domestic implementation of urgently needed unregistered drugs.

Ophthalmology

Leveraging profound experience in ophthalmic trials, we provide comprehensive support for research projects worldwide and drive progress in vision & ophthalmic healthcare.

Cardiovascular

Relying on a dynamic data integration platform to optimize the endpoint design of cardiovascular drug clinical trials.

Immunology & Inflammation

Possessing rich technological accumulation, combining stem cell therapy with immunomodulation strategies to optimize patient immune balance.

Dermatology

Develop innovative drugs through strategic cooperation, optimize clinical trial design for skin indications, and address challenges in skin efficacy assessment.

Neuroscience

Establish a standard system for clinical trials of drugs for the central nervous system, addressing challenges in cognitive assessment scales and patient compliance management.

Infectious Disease

Provide rapid clinical development solutions for antiviral drugs to address sudden infectious diseases (such as COVID-19), while enhancing data management and global collaboration.

Others

GCP ClinPlus provides full-service clinical trial support for medical devices, vaccines, herbal medicines with 22+ years experience.

Comprehensive Clinical Research Capabilities

From PreIND to Phase IV

IIT

Focus on the transformation of clinical needs, providing comprehensive support from protocol design to data management for medical institutions and research teams, integrating a global network of researchers and patient resources to accelerate the exploration of innovative therapies and the generation of real-world evidence.

View All

IIT

Early Phase Trials

Pivotal Trials

After-Approval Studies

Bioequivalence

Early Phase Trials

Specialize in early safety assessment and dose exploration for innovative drugs, efficiently completing high-difficulty projects with a trial success rate that ranks among the industry's leaders.

View All

IIT

Early Phase Trials

Pivotal Trials

After-Approval Studies

Bioequivalence

Pivotal Trials

Offer multi-center clinical trial design and execution services, achieving real-time monitoring and statistical analysis through a dynamic data platform, supporting joint development across China, the US, Europe, Japan, and South Korea.

View All

IIT

Early Phase Trials

Pivotal Trials

After-Approval Studies

Bioequivalence

After-Approval Studies

Supports pharmaceutical lifecycle management, deeply participates in the construction of domestic and international pharmacovigilance (PV) systems, assists clients in responding to regulatory inspections by FDA, EMA, and others.

View All

IIT

Early Phase Trials

Pivotal Trials

After-Approval Studies

Bioequivalence

Leverages bioanalytical laboratories compliant with FDA/EMA standards to provide end-to-end services, helping clients quickly complete consistency evaluation and global submissions.

View All

IIT

Early Phase Trials

Pivotal Trials

After-Approval Studies

Bioequivalence

Flexible & Scalable Delivery Models

Consulting

Focus on optimizing R&D strategy and risk prediction, providing customized solutions for pharmaceutical companies. Assist clients in scientific decision-making, reducing the risk of early investment.

Explore More

FSP Solutions

With a professional team embedded model, flexibly supplementing key functional gaps in the customer's R&D chain. Helping pharmaceutical companies quickly build multinational teams and reduce labor costs.

Explore More

Full Service Solutions

Offer one-stop delivery, taking the lead from solution design, trial execution to registration filing. This can shorten the R&D cycle and accelerate product market launch.

Explore More

Industry Insight

Gather valuable information and deliver industry insights

Regulatory Intelligence

Real-time tracking of global pharmaceutical regulatory updates, in-depth interpretation of the latest FDA, EMA, NMPA guidelines to help you accurately control R&D compliance.

Cases & Articles

Unveiling practical experience from clinical projects, sharing benchmark cases in oncology, CGT and other fields, providing reusable industry insights and solutions.

White Papers

Access to thematic white papers, unlocking cutting-edge technology methodologies and data insights.

Blog

Focus on innovation trends, share industry observations, empower scientific decision-making.

Accelerate Your Clinical Trials with a Trusted CRO Partner. Get a Free Consultation Today! View More

Solutions

Clinical Operations Biometrics Medical Writing Medical Monitoring Strategic & Registration Affairs Pharmacovigilance Quality Assurance Centralized Monitoring

Therapeutic Areas

Cell & Gene Therapy (CGT) Endocrinology & Metabolism Oncology Rare Disease Ophthalmology Cardiovascular Immunology & Inflammation Dermatology Neuroscience Infectious Disease Others

Capabilities

IIT Early Phase Trials Pivotal Trials After-Approval Studies Bioequivalence

Delivery Model

Consulting FSP Solutions Full Service Solutions

Quick Links

About Us Company News Exhibitions & Events Industry News Regulatory Intelligence Cases & Articles White Papers FAQs Blog Videos RFI / RFP Careers

Contact



Email:
global@GCP-ClinPlus.com



Tel:
+1 609-2553581



Add:
2005 Eastpark Blvd., Cranbury, New Jersey, USA, 08540



Headquarters Address:
Building 1, Hanwei International Zone 3, 186 South Fourth Ring West Road, Fengtai District, Beijing
Tel: +86 400-1006-531

Solutions

Clinical Operations Biometrics Medical Writing Medical Monitoring Strategic & Registration Affairs Pharmacovigilance Quality Assurance Centralized Monitoring

Therapeutic Areas

Cell & Gene Therapy (CGT) Endocrinology & Metabolism Oncology Rare Disease Ophthalmology Cardiovascular Immunology & Inflammation Dermatology Neuroscience Infectious Disease Others

Capabilities

IIT Early Phase Trials Pivotal Trials After-Approval Studies Bioequivalence

Quick Links

About Us Company News Exhibitions & Events Industry News Regulatory Intelligence Cases & Articles White Papers FAQs Blog Videos RFI / RFP Careers

2005 Eastpark Blvd., Cranbury, New Jersey, USA, 08540

Headquarters Address:
Building 1, Hanwei International Zone 3, 186 South Fourth Ring West Road, Fengtai District, Beijing
Tel: +86 400-1006-531

global@GCP-ClinPlus.com +1 609-2553581

Sitemap Privacy Policy

+1 609-2553581

We use cookies on this site, including third party cookies, to delivery experiennce for you. cookie policy to learn more.

Reject Accept Cookies